What is Chemify?
Chemify is at the forefront of reimagining the discovery and synthesis of novel molecules for pharmaceuticals and advanced materials. Through its proprietary Chemputation technology, which fuses robotics and artificial intelligence, the company transforms digital code into physical compounds. Headquartered in Glasgow, Scotland, Chemify was founded by Lee Cronin with the ambitious goal of digitalizing chemistry globally to benefit humanity. The company's innovative approach addresses critical needs in drug discovery and materials science, positioning it as a key player in the deep tech and biotech sectors.
How much funding has Chemify raised?
Chemify has raised a total of $93M across 2 funding rounds:
Series A
$43M
Series B
$50M
Series A (2023): $43M with participation from Possible Ventures and Horizon Ventures
Series B (2025): $50M led by Wing Venture Capital, Insight Partners, BlueYard Capital, Triatomic Capital, and 8VC
Key Investors in Chemify
Wing Venture Capital
Wing Venture Capital is an early-stage investor focused on equipping founders with resources and unwavering partnerships to develop innovative products, particularly in areas such as AI and autonomous applications.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing capital and operational support to help businesses scale.
BlueYard Capital
BlueYard Capital is a venture capital firm investing in innovative technologies across computation, engineering, and biology, supporting founders building solutions for a better future.
What's next for Chemify?
With this significant enterprise-level backing, Chemify is strategically positioned for accelerated growth and market expansion. The recent major strategic investment will likely fuel further research and development, enhance its Chemputation platform, and scale its operations to meet the growing demand for digitalized chemical synthesis. The company's focus on AI and robotics in chemistry suggests a trajectory towards becoming a foundational platform for future scientific innovation, potentially impacting drug development pipelines and the creation of next-generation materials. Chemify's continued advancement in this space indicates a strong potential for future breakthroughs and market leadership.
See full Chemify company page
